These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. A Thyroid Hormone-Based Strategy for Correcting the Biochemical Abnormality in X-Linked Adrenoleukodystrophy. Hartley MD; Kirkemo LL; Banerji T; Scanlan TS Endocrinology; 2017 May; 158(5):1328-1338. PubMed ID: 28200172 [TBL] [Abstract][Full Text] [Related]
43. Co-expression of mutated and normal adrenoleukodystrophy protein reduces protein function: implications for gene therapy of X-linked adrenoleukodystrophy. Unterrainer G; Molzer B; Forss-Petter S; Berger J Hum Mol Genet; 2000 Nov; 9(18):2609-16. PubMed ID: 11063720 [TBL] [Abstract][Full Text] [Related]
44. Silencing of Abcd1 and Abcd2 genes sensitizes astrocytes for inflammation: implication for X-adrenoleukodystrophy. Singh J; Khan M; Singh I J Lipid Res; 2009 Jan; 50(1):135-47. PubMed ID: 18723473 [TBL] [Abstract][Full Text] [Related]
45. Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy. Galino J; Ruiz M; Fourcade S; Schlüter A; López-Erauskin J; Guilera C; Jove M; Naudi A; García-Arumí E; Andreu AL; Starkov AA; Pamplona R; Ferrer I; Portero-Otin M; Pujol A Antioxid Redox Signal; 2011 Oct; 15(8):2095-107. PubMed ID: 21453200 [TBL] [Abstract][Full Text] [Related]
46. C26:0-Carnitine Is a New Biomarker for X-Linked Adrenoleukodystrophy in Mice and Man. van de Beek MC; Dijkstra IM; van Lenthe H; Ofman R; Goldhaber-Pasillas D; Schauer N; Schackmann M; Engelen-Lee JY; Vaz FM; Kulik W; Wanders RJ; Engelen M; Kemp S PLoS One; 2016; 11(4):e0154597. PubMed ID: 27124591 [TBL] [Abstract][Full Text] [Related]
47. Very long chain fatty acid β-oxidation in astrocytes: contribution of the ABCD1-dependent and -independent pathways. Morita M; Shinbo S; Asahi A; Imanaka T Biol Pharm Bull; 2012; 35(11):1972-9. PubMed ID: 23123468 [TBL] [Abstract][Full Text] [Related]
48. ABC Transporter Subfamily D: Distinct Differences in Behavior between ABCD1-3 and ABCD4 in Subcellular Localization, Function, and Human Disease. Kawaguchi K; Morita M Biomed Res Int; 2016; 2016():6786245. PubMed ID: 27766264 [TBL] [Abstract][Full Text] [Related]
50. Detection of Characteristic Phosphatidylcholine Containing Very Long Chain Fatty Acids in Cerebrospinal Fluid from Patients with X-Linked Adrenoleukodystrophy. Fujitani N; Saito M; Akashi T; Morita M; So T; Oka K Biol Pharm Bull; 2022; 45(11):1725-1727. PubMed ID: 36328509 [TBL] [Abstract][Full Text] [Related]
51. Differential substrate specificities of human ABCD1 and ABCD2 in peroxisomal fatty acid β-oxidation. van Roermund CW; Visser WF; Ijlst L; Waterham HR; Wanders RJ Biochim Biophys Acta; 2011 Mar; 1811(3):148-52. PubMed ID: 21145416 [TBL] [Abstract][Full Text] [Related]
52. Role of family D ATP-binding cassette transporters (ABCD) in cancer. Hlaváč V; Souček P Biochem Soc Trans; 2015 Oct; 43(5):937-42. PubMed ID: 26517907 [TBL] [Abstract][Full Text] [Related]
53. Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients. Jang J; Kang HC; Kim HS; Kim JY; Huh YJ; Kim DS; Yoo JE; Lee JA; Lim B; Lee J; Yoon TM; Park IH; Hwang DY; Daley GQ; Kim DW Ann Neurol; 2011 Sep; 70(3):402-9. PubMed ID: 21721033 [TBL] [Abstract][Full Text] [Related]
54. [X-linked adrenoleukodystrophy]. Aubourg P Ann Endocrinol (Paris); 2007 Dec; 68(6):403-11. PubMed ID: 17532287 [TBL] [Abstract][Full Text] [Related]